CVE-2026-41360
5.4
CVSS:4.0/AV:L/AC:H/AT:N/PR:L/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N
Summary
OpenClaw before 2026.4.2 contains an approval integrity vulnerability in pnpm dlx that fails to bind local script operands consistently with pnpm exec flows. Attackers can replace approved local scripts before execution without invalidating the approval plan, allowing execution of modified script contents.
Affected Software
| Vendor | Product | Version Range | Status |
|---|---|---|---|
| OpenClaw | OpenClaw | 0 < 2026.4.2 | affected |
| OpenClaw | OpenClaw | 2026.4.2 | unaffected |
Weaknesses
- CWE-367: CWE-367: Time-of-check Time-of-use (TOCTOU) Race Condition
ADP Enrichment
CISA ADP Vulnrichment
- SSVC:
- Exploitation: none
- Automatable: no
- Technical Impact: total
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-w6wx-jq6j-6mcj
- https://github.com/openclaw/openclaw/commit/176c059b05357df1bc09d4328a2380670859eeff
- https://www.vulncheck.com/advisories/openclaw-approval-integrity-bypass-in-pnpm-dlx-local-script-binding
Feedback
Was this page helpful?
Glad to hear it! Please tell us how we can improve.
Sorry to hear that. Please tell us how we can improve.